Shire to test its ADHD drug in 4 to 5-year olds in U.S.

Shire Plc SHP.L has agreed to a U.S. Food and Drug Administration request to study its stimulant Vyvanse in preschool children as concern rises over the diagnosis and treatment of attention deficit hyperactivity disorder, the drugmaker said on Thursday. A report last year by the Centers for Disease Control and Prevention found that the number of children diagnosed with ADHD increased 41 percent from 2003 to 2011 and that 6.4 million children, or 11 percent of those aged 4 to 17, have been diagnosed with that condition. Drugs treatments include Ritalin, Adderall and Vyvanse. Only Adderall, which is also made by Shire, is approved to treat children under the age of 6.
Medications/Drugs News Headlines – Yahoo! News

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us